These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1346567)

  • 1. Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro.
    McClure MO; Moore JP; Blanc DF; Scotting P; Cook GM; Keynes RJ; Weber JN; Davies D; Weiss RA
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):19-26. PubMed ID: 1346567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.
    Lederman S; Gulick R; Chess L
    J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.
    Witvrouw M; De Clercq E
    Gen Pharmacol; 1997 Oct; 29(4):497-511. PubMed ID: 9352294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfated polysaccharides (chondroitin sulfate and carrageenan) plus glucosamine sulfate are potent inhibitors of HIV.
    Konlee M
    Posit Health News; 1998; (No 17):4-7. PubMed ID: 11366556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection.
    Lynch G; Low L; Li S; Sloane A; Adams S; Parish C; Kemp B; Cunningham AL
    J Leukoc Biol; 1994 Sep; 56(3):266-72. PubMed ID: 7521897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maleylated human serum albumin inhibits HIV-1 infection in vitro.
    Takami M; Sone T; Mizumoto K; Kino K; Tsunoo H
    Biochim Biophys Acta; 1992 Dec; 1180(2):180-6. PubMed ID: 1281431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1.
    Pearce-Pratt R; Phillips DM
    Biol Reprod; 1996 Jan; 54(1):173-82. PubMed ID: 8838015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-derived peptide and sulfated polysaccharides have similar mechanisms of anti-HIV activity based on electrostatic interactions with positively charged gp120 fragments.
    Meshcheryakova D; Andreev S; Tarasova S; Sidorova M; Vafina M; Kornilaeva G; Karamov E; Khaitov R
    Mol Immunol; 1993 Aug; 30(11):993-1001. PubMed ID: 8102473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of CD4 with HIV-1 gp120.
    Silberman SL; Goldman SJ; Mitchell DB; Tong AT; Rosenstein Y; Diamond DC; Finberg RW; Schreiber SL; Burakoff SJ
    Semin Immunol; 1991 May; 3(3):187-92. PubMed ID: 1888898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.
    Jagodzinski PP; Wustner J; Kmieciak D; Wasik TJ; Fertala A; Sieron AL; Takahashi M; Tsuji T; Mimura T; Fung MS; Gorny MK; Kloczewiak M; Kaneko Y; Kozbor D
    Virology; 1996 Dec; 226(2):217-27. PubMed ID: 8955041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of polyanion-resistance on HIV-1 infection.
    Bobardt MD; Armand-Ugón M; Clotet I; Zhang Z; David G; Este JA; Gallay PA
    Virology; 2004 Aug; 325(2):389-98. PubMed ID: 15246277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor.
    Schols D; Baba M; Pauwels R; Desmyter J; De Clercq E
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3322-6. PubMed ID: 2566170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
    Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.
    Nakashima H; Yoshida O; Tochikura TS; Yoshida T; Mimura T; Kido Y; Motoki Y; Kaneko Y; Uryu T; Yamamoto N
    Jpn J Cancer Res; 1987 Nov; 78(11):1164-8. PubMed ID: 2447045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of entry of HIV into cells by poly(A).poly(U).
    Krust B; Callebaut C; Hovanessian AG
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1087-90. PubMed ID: 8312051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfated alkyl oligosaccharides with potent inhibitory effects on human immunodeficiency virus infection.
    Uryu T; Ikushima N; Katsuraya K; Shoji T; Takahashi N; Yoshida T; Kanno K; Murakami T; Nakashima H; Yamamoto N
    Biochem Pharmacol; 1992 Jun; 43(11):2385-92. PubMed ID: 1351727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
    Hamza A; Zhan CG
    J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
    Tamamura H; Otaka A; Murakami T; Ishihara T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Biochem Biophys Res Commun; 1996 Feb; 219(2):555-9. PubMed ID: 8605026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
    Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.